Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

72
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
72
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

297
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
297
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

192
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
192
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

73
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
73
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

74
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Unravelling the Intrinsic Reactivity and Colloidal Instability in Tin-Based Halide Perovskite Precursor Solutions.

Angewandte Chemie (International ed. in English)·2026
Same author

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Advancing Quantitative <sup>31</sup>P NMR Spectroscopy for Reliable Thiol Group Analysis.

ACS macro letters·2026
Same author

Nanosized Li<sub>2</sub>S-Loaded Polar Porous Carbon Nanofibers as Self-Supporting Electrodes in Anode-Free Lithium-Sulfur Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Small-Angle X-ray Scattering Monitoring of Porosity Evolution in Iron-Nitrogen-Carbon Electrocatalysts.

ACS nano·2025

Related Experiment Video

Updated: Mar 18, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.1K

Advancing Drug Formulation Additives toward Precision Additives with Release Mediating Peptide Interlayer.

Sebastian Wieczorek, André Dallmann, Zdravko Kochovski1

  • 1Soft Matter and Functional Materials, Helmholtz-Zentrum Berlin für Materialien und Energie , Hahn-Meitner-Platz 1, Berlin, Germany.

Journal of the American Chemical Society
|July 12, 2016
PubMed
Summary

New drug formulation additives using palmitic acid-poly(ethylene glycol) (Pal-PEG) and a specific peptide precisely control drug release. This innovation enhances drug solubility and delivery kinetics for advanced therapeutic applications.

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.1K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.8K

Area of Science:

  • Drug delivery systems
  • Polymer chemistry
  • Bioconjugate chemistry

Background:

  • Developing effective drug delivery systems is crucial for therapeutic success.
  • Current formulations often face challenges with drug solubility, stability, and controlled release.
  • Poly(ethylene glycol) (PEG) is widely used for its solubility and biocompatibility, while hydrophobic components can aid drug loading.

Purpose of the Study:

  • To develop novel amphiphilic drug formulation additives for precise control over drug release profiles.
  • To create a system that enhances drug solubility and achieves high drug loading capacity.
  • To investigate the role of a tailored peptide in modulating drug activation kinetics.

Main Methods:

  • Synthesized amphiphilic additives based on palmitic acid-modified poly(ethylene glycol) (Pal-PEG).
  • Incorporated a drug-binding peptide selected via combinatorial methods at the hydrophobic-hydrophilic interface.
  • Formulated a photosensitizer drug using the developed additives.
  • Evaluated drug loading, solubility, and release kinetics, including activation modulation.

Main Results:

  • The Pal-PEG additives achieved high drug payloads, approaching a 1:1 ratio.
  • The formulation successfully rendered a photosensitizer water-soluble.
  • Fine-tuning the peptide interface layer allowed for adjustable drug activation kinetics.
  • The peptide enabled precise modulation of drug release profiles.

Conclusions:

  • Pal-PEG based additives with tailored peptides offer a versatile platform for advanced drug formulation.
  • This approach provides enhanced solubility, high drug loading, and tunable release/activation kinetics.
  • The system holds promise for improving the efficacy and delivery of various therapeutic agents, including photosensitizers.